These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 30268481)

  • 1. Applicability of a prognostic CT-based radiomic signature model trained on stage I-III non-small cell lung cancer in stage IV non-small cell lung cancer.
    de Jong EEC; van Elmpt W; Rizzo S; Colarieti A; Spitaleri G; Leijenaar RTH; Jochems A; Hendriks LEL; Troost EGC; Reymen B; Dingemans AC; Lambin P
    Lung Cancer; 2018 Oct; 124():6-11. PubMed ID: 30268481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative nomogram of CT imaging, clinical, and hematological features for survival prediction of patients with locally advanced non-small cell lung cancer.
    Wang L; Dong T; Xin B; Xu C; Guo M; Zhang H; Feng D; Wang X; Yu J
    Eur Radiol; 2019 Jun; 29(6):2958-2967. PubMed ID: 30643940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of early onset, CT derived loss of muscle and adipose tissue during chemotherapy in metastatic non-small cell lung cancer.
    Degens JHRJ; Sanders KJC; de Jong EEC; Groen HJM; Smit EF; Aerts JG; Schols AMWJ; Dingemans AC
    Lung Cancer; 2019 Jul; 133():130-135. PubMed ID: 31200819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival prediction of non-small cell lung cancer patients using radiomics analyses of cone-beam CT images.
    van Timmeren JE; Leijenaar RTH; van Elmpt W; Reymen B; Oberije C; Monshouwer R; Bussink J; Brink C; Hansen O; Lambin P
    Radiother Oncol; 2017 Jun; 123(3):363-369. PubMed ID: 28506693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT derived radiomic score for predicting the added benefit of adjuvant chemotherapy following surgery in stage I, II resectable non-small cell lung cancer: a retrospective multicohort study for outcome prediction.
    Vaidya P; Bera K; Gupta A; Wang X; Corredor G; Fu P; Beig N; Prasanna P; Patil PD; Velu PD; Rajiah P; Gilkeson R; Feldman MD; Choi H; Velcheti V; Madabhushi A
    Lancet Digit Health; 2020 Mar; 2(3):e116-e128. PubMed ID: 33334576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a Radiomic Signature Developed in a General NSCLC Cohort for Predicting Overall Survival of ALK-Positive Patients With Different Treatment Types.
    Huang L; Chen J; Hu W; Xu X; Liu D; Wen J; Lu J; Cao J; Zhang J; Gu Y; Wang J; Fan M
    Clin Lung Cancer; 2019 Nov; 20(6):e638-e651. PubMed ID: 31375452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Draw on advantages and avoid disadvantages: CT-derived individualized radiomic signature for predicting chemo-radiotherapy sensitivity in unresectable advanced non-small cell lung cancer.
    Yang L; Li M; Liu Y; Jiang Z; Xu S; Ding H; Gao X; Liu S; Qi L; Wang K
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):453. PubMed ID: 39387925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CT-based radiomic signature predicts distant metastasis in lung adenocarcinoma.
    Coroller TP; Grossmann P; Hou Y; Rios Velazquez E; Leijenaar RT; Hermann G; Lambin P; Haibe-Kains B; Mak RH; Aerts HJ
    Radiother Oncol; 2015 Mar; 114(3):345-50. PubMed ID: 25746350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new PET/CT volumetric prognostic index for non-small cell lung cancer.
    Zhang H; Wroblewski K; Jiang Y; Penney BC; Appelbaum D; Simon CA; Salgia R; Pu Y
    Lung Cancer; 2015 Jul; 89(1):43-9. PubMed ID: 25936471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal radiomics of cone-beam CT images from non-small cell lung cancer patients: Evaluation of the added prognostic value for overall survival and locoregional recurrence.
    van Timmeren JE; van Elmpt W; Leijenaar RTH; Reymen B; Monshouwer R; Bussink J; Paelinck L; Bogaert E; De Wagter C; Elhaseen E; Lievens Y; Hansen O; Brink C; Lambin P
    Radiother Oncol; 2019 Jul; 136():78-85. PubMed ID: 31015133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative CT-based radiomic prognostic index to predict the benefit of postoperative radiotherapy in patients with non-small cell lung cancer: a multicenter study.
    Ma Z; Men Y; Liu Y; Bao Y; Liu Q; Yang X; Wang J; Deng L; Zhai Y; Bi N; Wang L; Hui Z
    Cancer Imaging; 2024 May; 24(1):61. PubMed ID: 38741207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
    Huynh E; Coroller TP; Narayan V; Agrawal V; Hou Y; Romano J; Franco I; Mak RH; Aerts HJ
    Radiother Oncol; 2016 Aug; 120(2):258-66. PubMed ID: 27296412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting pathologic response to neoadjuvant chemoradiation in resectable stage III non-small cell lung cancer patients using computed tomography radiomic features.
    Khorrami M; Jain P; Bera K; Alilou M; Thawani R; Patil P; Ahmad U; Murthy S; Stephans K; Fu P; Velcheti V; Madabhushi A
    Lung Cancer; 2019 Sep; 135():1-9. PubMed ID: 31446979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiomics signature: A potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology.
    Tu W; Sun G; Fan L; Wang Y; Xia Y; Guan Y; Li Q; Zhang D; Liu S; Li Z
    Lung Cancer; 2019 Jun; 132():28-35. PubMed ID: 31097090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology-based radiomic features for prediction of the prognosis of lung cancer based on CT-based radiomics.
    Kadoya N; Tanaka S; Kajikawa T; Tanabe S; Abe K; Nakajima Y; Yamamoto T; Takahashi N; Takeda K; Dobashi S; Takeda K; Nakane K; Jingu K
    Med Phys; 2020 Jun; 47(5):2197-2205. PubMed ID: 32096876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
    Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
    Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
    Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
    Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CT-Based Radiomic Signature as a Prognostic Factor in Stage IV
    Li H; Zhang R; Wang S; Fang M; Zhu Y; Hu Z; Dong D; Shi J; Tian J
    Front Oncol; 2020; 10():57. PubMed ID: 32133282
    [No Abstract]   [Full Text] [Related]  

  • 19. The prognostic value of KRAS mutated plasma DNA in advanced non-small cell lung cancer.
    Nygaard AD; Garm Spindler KL; Pallisgaard N; Andersen RF; Jakobsen A
    Lung Cancer; 2013 Mar; 79(3):312-7. PubMed ID: 23238036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome prediction in resectable lung adenocarcinoma patients: value of CT radiomics.
    Choe J; Lee SM; Do KH; Kim S; Choi S; Lee JG; Seo JB
    Eur Radiol; 2020 Sep; 30(9):4952-4963. PubMed ID: 32356158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.